Advanced Disposal Services Announces Potential IPO Pricing
Advanced Disposal Services shares are expected to price in the range of $20 to $22 per share, valuing the initial public offering at roughly $500 million.
All Work
Chris Lange
PLx Pharma Gets Closer to IPO Debut
More than 3 million PLx Pharma shares are expected to price in the range of $17 to $19 per share in an initial public offering valued up to about $83 million.
Neos Therapeutics Gears Up for Secondary Offering
Neos Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its secondary offering.
Could This Be the Turning Point for TrovaGene?
Despite being a small medical laboratory and research firm, TrovaGene offered cover for investors in Monday's session from a downturn in the broad markets.
Is Alere Really Worth the 50% Premium?
Alere absolutely skyrocketed in Monday’s regular session following the announcement that it will be acquired by Abbott Laboratories.
What to Expect From Alphabet Earnings
Alphabet is scheduled to report its fourth-quarter financial results after the markets close on Monday.
Exelixis Rises on Positive Late-Stage Trial Results
Exelixis shares were rising early Monday following the release of positive results from its late-stage trial of cabozantinib.
How Analysts See Qualcomm After Earnings
A couple of key analysts weighed in on the semiconductor giant Qualcomm after its fiscal first-quarter earnings report.
3 Key FDA Decisions Expected in February
24/7 Wall St. has collected three big FDA decisions coming up in February and added some color, along with the trading range and price target.
How Analysts See Juniper Networks After a Bad Earnings Reaction
Juniper Networks cratered following the release of its fourth-quarter earnings last week. As a result, the company was hit with a barrage of analyst calls, mostly cutting the price target.
Top 3 Dow Earnings for the Coming Week
24/7 Wall St. has put together a preview of the three Dow Jones Industrial Average companies that are reporting their quarterly results this week.
Are Analysts and Investors Getting Too Down on eBay?
As a result analysts piled on to the stock, but they may have been overly negative, considering the earnings report.
Why Analysts Are Even More Bullish on Facebook for 2016 and Beyond
24/7 Wall St. has highlighted a few of the important points of the Facebook quarterly report and reviewed what analysts were saying afterward.
Despite Target Cuts, Analysts Stick With Incyte for Big Upside
After the announcement that its Phase 2 trial of Ruxolitinib would be stopped a few analysts took a deeper look at Incyte and realized that it might not be as bad as initially thought.
Is Seagate Turning Around in 2016?
Seagate Technology reported better-than-expected fiscal second-quarter before the markets opened Friday.
Westlake and Axiall Merger: A Swing and a Miss
Westlake Chemical announced that it submitted a proposal to acquire all outstanding shares of Axiall for $20 apiece, but the bid was rejected by the Axiall board.
Hedge Fund Manager Agrees With SEC to Reimburse Investor Losses
The SEC announced on Friday that a Manhattan-based investment advisory firm and its Toronto-based hedge fund manager have agreed to settle charges that they misled investors.
Why MasterCard Investors Liked Q1 Earnings Beat
MasterCard reported mixed fiscal first-quarter financial results after the markets closed Thursday.
Investors Were Not Impressed With AbbVie Q4 Earnings
AbbVie reported mixed fourth-quarter financial results after the markets closed Thursday.
EA Trips Over Guidance, Even With Star Wars: Battlefront
Electronic Arts reported better-than-expected fiscal third-quarter financial results after the markets closed Thursday.